Whitworth, Pat <br/><br/>
Chemosensitivity and Endocrine Sensitivity in Clinical Luminal Breast Cancer Patients in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST) Predicted by Molecular Subtyping.  [electronic resource] 

 -  Annals of surgical oncology  Mar 2017 
 - 669-675 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Comparative Study; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1534-4681 
<br/><br/><label>Standard No.: </label>10.1245/s10434-016-5600-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anastrozole<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--classification<br/>Bridged-Ring Compounds--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Clinical Decision-Making<br/>Cyclophosphamide--administration & dosage<br/>Docetaxel<br/>Doxorubicin--administration & dosage<br/>Female<br/>Gene Expression Profiling<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Letrozole<br/>Mastectomy, Segmental<br/>Middle Aged<br/>Molecular Typing--methods<br/>Neoadjuvant Therapy<br/>Nitriles--administration & dosage<br/>Prospective Studies<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Registries<br/>Tamoxifen--administration & dosage<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>Triazoles--administration & dosage<br/>Young Adult